Biocept Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Biocept Inc inventory turnover ratio, the Biocept Inc 's ability to sell and replace its inventory in the second quarter 2023, sequentially increased to 16.02 in the second quarter 2023, yet the ratio remained below the average, as BIOC's market remain challenging.Average inventory processing period, for the Biocept Inc in Jun 30 2023 quarter, has decreased to 23 days, compare to 24 days, in the Mar 31 2023 quarter.

Within Healthcare sector 16 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2023, to 218, from total ranking in the first quarter 2023 at 232.

BIOC Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Biocept Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

BIOC Inventory Turnover Ratio	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter	(Dec 31 2022) IV. Quarter	(Sep 30 2022) III. Quarter	(Jun 30 2022) II. Quarter
Y / Y Inventory Growth	-75.5 %	-78.14 %	-71.44 %	1797 %	3648.33 %
Y / Y Cost of Sales Growth	-68.22 %	-70.7 %	-60.87 %	-48.73 %	7.52 %
Inventory Turnover Ratio (TTM)	16.02	15.08	14	14.03	19.77
BIOC's Total Ranking	# 218	# 232	# 325	# 240	# 220
Average inventory processing period	23	24	26	26	18
Seq. Inventory Growth	-21.73 %	-7 %	-60.09 %	-15.65 %	-30.18 %
Seq. Cost of Sales Growth	-15.79 %	-29.68 %	-25.45 %	-28.01 %	-22.37 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Medical Laboratories Industry	# 2
Healthcare Sector	# 17
Overall Market	# 218

Inventory Turnover Ratio Statistics
High	Average	Low
28.23	16.15	9.5
(Sep 30 2021)		(Sep 30 2020)

BIOC Company Profile >> Back to BIOC Efficiency Comparisons >> Compare BIOC Inventory Turnover Ratio to its Competitors

Financial Statements
Biocept Inc 's Inventories	$ 1 Millions	Visit BIOC's Balance sheet
Biocept Inc 's Cost of Revenues TTM	$ 16 Millions	Visit BIOC's Income Statement
What are BIOC's Sales?		Visit BIOC's Sales by Segment

Other Inventory Turnover Ratios
Biocept Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Laboratories Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
BIOC's Inventory Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for BIOC's Competitors
Inventory Turnover Ratio for BIOC's Suppliers
Inventory Turnover Ratio for BIOC's Customers

You may also want to know
BIOC's Sales Growth Rates	BIOC's Pe Price to earnings ratio	BIOC's Receivables Turnover Ratio	BIOC's Stock Quote
BIOC's Net Income Growth Rates	BIOC's Ps Price to Sales ratio	BIOC's Sales per Employee	BIOC's Asset Turnover Ratio
BIOC's Net Margin	BIOC's Pb Price to Book ratio	BIOC's Financial Strength Ratios	BIOC's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2023, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Jun 30 2023	Inventories at quarter ending Jun 30 2023
Healthcare Services Group Inc	70.09	$ 1,473.398 Millions	$ 21 Millions
Quest Diagnostics Inc	33.64	$ 6,299.000 Millions	$ 187 Millions
Rennova Health Inc	29.19	$ 7.509 Millions	$ 0 Millions
Scienture Holdings Inc	27.30	$ 3.297 Millions	$ 0 Millions
The Oncology Institute Inc	24.80	$ 258.579 Millions	$ 10 Millions
Intelgenx Technologies Corp	24.61	$ 1.815 Millions	$ 0 Millions
Harmony Biosciences Holdings inc	22.32	$ 95.632 Millions	$ 4 Millions
Labcorp Holdings Inc	21.48	$ 10,245.500 Millions	$ 477 Millions
Adapthealth Corp	21.23	$ 2,674.829 Millions	$ 126 Millions
Vaso Corporation	20.08	$ 31.290 Millions	$ 2 Millions
Vanda Pharmaceuticals Inc	16.77	$ 20.831 Millions	$ 1 Millions
Viemed Healthcare Inc	16.76	$ 61.477 Millions	$ 4 Millions
Biocept Inc	16.02	$ 15.660 Millions	$ 1 Millions
Novavax inc	15.98	$ 706.221 Millions	$ 44 Millions
Teladoc Health Inc	15.45	$ 755.139 Millions	$ 49 Millions
Invitae Corporation	15.40	$ 385.716 Millions	$ 25 Millions
Aspira Women s Health inc	13.32	$ 3.895 Millions	$ 0 Millions
Natera Inc	13.31	$ 529.903 Millions	$ 40 Millions
Option Care Health Inc	13.17	$ 3,204.135 Millions	$ 243 Millions
23andme Holding Co	13.04	$ 155.970 Millions	$ 12 Millions
Eton Pharmaceuticals Inc	12.97	$ 7.428 Millions	$ 1 Millions
Wearable Health Solutions, Inc.	12.96	$ 0.477 Millions	$ 0 Millions
Lantheus Holdings Inc	12.92	$ 530.615 Millions	$ 41 Millions
Precipio inc	12.72	$ 7.802 Millions	$ 1 Millions
Rockwell Medical inc	12.22	$ 67.973 Millions	$ 6 Millions
Qhslab Inc	11.70	$ 0.620 Millions	$ 0 Millions
Rvl Pharmaceuticals Plc	11.28	$ 8.384 Millions	$ 1 Millions
Sotera Health Company	10.95	$ 446.648 Millions	$ 41 Millions
Agile Therapeutics Inc	10.71	$ 21.081 Millions	$ 2 Millions
Myriad Genetics Inc	10.54	$ 221.300 Millions	$ 21 Millions

Date modified: 2026-09-08T15:11:02+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.